The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Experts Discuss Rheumatologists’ Role in Treating Depression, Anxiety and Psychological Comorbidities in Their Patients

Experts Discuss Rheumatologists’ Role in Treating Depression, Anxiety and Psychological Comorbidities in Their Patients

December 17, 2017 • By Larry Beresford

  • Tweet
  • Email
Print-Friendly Version / Save PDF

“Rheumatologic diseases come with emotional fallout. They can change the course of a person’s life and adversely affect their sense of self. We can add to that neurobiological factors, with new evidence suggesting depression itself may be a type of inflammatory disease,” she says.

You Might Also Like
  • Depression & Anxiety Linked to Poor Rheumatoid Arthritis Outcomes
  • Anxiety, Depression May Help Predict Outcome of Low Back Pain Treatment
  • Tips for Treating Pain, Depression in Patients with Rheumatic Disease Offered at the ACR/ARHP’s 2013 Annual Meeting
Explore This Issue
December 2017
Also By This Author
  • Bringing Consistency to Gout Terms & Concepts
Dr. Evers

Dr. Evers

Not all rheumatology patients have depression, notes Andrea Evers, PhD, professor of health psychology and chair of the Health, Medical and Neuropsychology Unit at Leiden University in The Netherlands. “A majority of our patients can handle a condition like rheumatoid arthritis in their lives with their existing coping resources. But rheumatologists struggle with a subgroup of patients who are prone to depression,” she says. “Sometimes, the mental health issue is independent of the disease. But we know people with high levels of rheumatic disease are already experiencing stress, which in turn has a close relationship with rheumatologic disease.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

What Does the Research Tell Us?

Research has demonstrated prevalence of depression and anxiety in such conditions as rheumatoid arthritis at double the rates in the general population, and milder levels of psychological distress are even more common.1 Studies report ranges of depression from 5–20% in patients with RA.2

Symptoms of depression and anxiety are also associated with poorer health outcomes, increased disability and reduced treatment response, and with worse health-related quality of life.3,4 But only a fraction of those with depression and anxiety receive treatment for those symptoms.5

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Fatigue in RA is also associated with psychological correlates, especially poor mood.6 There is a relationship between stress and exacerbation of RA, and between resilience factors and RA management.7 Researchers have also documented the impact of psychological factors on patients’ responses to RA treatment.8

Loneliness has been shown to have an impact on patients’ daily pain in fibromyalgia, and loneliness and lack of social support are possible risk factors for worse physical and psychological functioning in a variety of somatic conditions, including RA and fibromyalgia.9,10 Rheumatology research has even identified connections with premature mortality. One recent study suggests treatment with antidepressants can lead to RA remission, and others have asked if it is possible to accurately identify a fibromyalgia or RA personality.11-13

A lot of people are trying to figure out cause and effect, says Faith Matcham, PhD, CPsychol, a post-doctoral research associate at the Institute of Psychiatry, Psychology and Neuroscience at Kings College, London, England. “I don’t think that’s the most important question, but rather how do these two things relate to each other? If you have one, how does it interact with the other?” she explains.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 6 | Single Page

Filed Under: Conditions, Practice Management Tagged With: anxiety, behavioral, cognitive, comorbidities, Depression, fatigue, Fibromyalgia, Lupus, Management, Mental Health, patient care, psychological, quality of life, RA, Rheumatoid arthritis, rheumatologic conditions, rheumatologist, rheumatology, SLE, therapy, TreatmentIssue: December 2017

You Might Also Like:
  • Depression & Anxiety Linked to Poor Rheumatoid Arthritis Outcomes
  • Anxiety, Depression May Help Predict Outcome of Low Back Pain Treatment
  • Tips for Treating Pain, Depression in Patients with Rheumatic Disease Offered at the ACR/ARHP’s 2013 Annual Meeting
  • Depression May Increase Risk of Cardiovascular Disease for RA Patients

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.